THREAD and CureClick Partner in DCT Recruitment
THREAD and CureClick have announced a new partnership focused on engaging social media influencers to increase recruitment outcomes in decentralized clinical trials (DCTs). Combining THREAD’s platform with CureClick’s network of more than 100,000 patient activists and advocates, influencers can now highlight potentially life-saving DCTs within targeted social media networks to possibly achieve increased enrollment, retention, and satisfaction rates.
CureClick increases clinical trial awareness and accelerates patient recruitment by enabling trusted members of online communities to easily find and disseminate accurate, patient-friendly information across their social networks. Through this partnership, CureClick patient activists, or “ambassadors,” will deliver eligible participants to THREAD’s automated participant recruitment and onboarding solution.
For more information, click here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
